Table 6 Deterministic results for all strategies for the morbidity-related outcomes at 2 years
Pathway | Cost | Incremental cost | Effectiveness | Incremental effectiveness | ICER | Remarks |
|---|---|---|---|---|---|---|
Survival for 2 years | ||||||
IFL | £9367 | 0.9645 | ||||
Blue dye+ultrastaging | £9775 | £408 | 0.9427 | Dominated | ||
Blue dye+H&E | £9826 | 0.8782 | Dominated | |||
99mTc +ultrastaging | £10 175 | £400 | 0.9345 | Dominated | ||
99mTc+H&E | £10 245 | 0.8457 | Dominated | |||
99mTc+blue dye+ultrastaging | £10 576 | £400 | 0.9335 | Dominated | ||
99mTc+blue dye+H&E | £10 648 | 0.8418 | Dominated | |||
Survival free of morbidity for 2 years | ||||||
IFL | £9367 | 0.3512 | ||||
Blue dye+ultrastaging | £9775 | £408 | 0.5241 | 0.1729 | £2400 | |
Blue dye+H&E | £9826 | 0.5015 | Dominated | |||
99mTc +ultrastaging | £10 175 | £400 | 0.6054 | 0.0813 | £4900 | |
99mTc+H&E | £10 245 | 0.5744 | Dominated | |||
99mTc+blue dye+ultrastaging | £10 576 | £400 | 0.6151 | 0.0097 | £41 200 | |
99mTc+blue dye+H&E | £10 648 | 0.5830 | Dominated | |||
Survival free of long-term morbidity for 2 years | ||||||
IFL | £9367 | 0.6423 | ||||
Blue dye+ultrastaging | £9775 | £408 | 0.7534 | 0.1111 | £3700 | |
Blue dye+H&E | £9826 | 0.7105 | Dominated | |||
99mTc+ultrastaging | £10 175 | £400 | 0.7985 | 0.0451 | £8900 | |
99mTc+H&E | £10 245 | 0.7395 | Dominated | |||
99mTc+blue dye+ultrastaging | £10 576 | £400 | 0.8039 | 0.0054 | £74 300 | |
99mTc+blue dye+H&E | £10 648 | 0.7430 | Dominated | |||
